HPV Testing and PAP Testing Market: By Type, By Application, By End User, and Geography

HPV Testing and PAP Testing Market Size, Share, Growth, Trends, and Global Industry Analysis: By Type (Primary HPV Testing, PAP Testing, Co-testing), By Application (Cervical cancer, Vaginal Cancer), By End User (Hospital, Diagnostic Centres, Research Institute, Others), and Region

HPV Testing and PAP Testing Market size was valued at US$ 2,567.2 million in 2023 and is poised to grow at a CAGR of 17.1% from 2024-2030. The HPV (Human Papillomavirus) testing is a test done to detect the presence of Papillomavirus in women, which causes cervical cancer or development of genital warts. Factors such as government initiative and funding programs and technological advancement in PAP and HPV test, change in screening guidelines, increasing awareness among the people about the screening program of cervical cancer worldwide and growing ageing population and increasing prevalence of cervical cancer cases are impacting the market growth. According to WHO, cervical cancer is the fourth most common cancer in women globally and around 6,60,000 new cases and 3,50,000 deaths have been seen in 2022. The highest rates of cervical cancer are reported in low income and middle- income countries and is more common in women of age group 25-55 years. This high rate of cervical cancer is due to the lack of access to National HPV vaccination, cervical screening and treatment services, also social and economic determinants are some other factors too.

There are other limiting factors also, for example, in US although free or low-cost cervical cancer screening is available for women aged 21-64 but not all women respond to these invitations. And this is commonly seen in people from particular ethnic and socioeconomic groups, low-income groups, recent immigrants. Significant change in regulatory guidelines for cervical cancer screening which will restraint the growth of this market. As per American Cancer Society, HPV test detect HPV infection and can not detect pre cancer or cancer itself whereas PAP test finds changes in the cells or abnormal cells in the cervix and cannot detect HPV. With more people detecting and treating abnormal cervical cell changes early, the market for cervical cancer prevention is projected to grow in the coming years.

HPV Testing and PAP Testing Market Key Developments:
  • In 2022: Roche launched the self-diagnosing and self-sampling method/solution for HPV in CE certification recognised countries.
  • In 2021: Hologic, Inc. acquired a privately held European developer and manufacturer of molecular diagnostic assays (DIAGENODE) for approximately $159 million.
  • In 2021: QIAGEN N.V launched QIAcube Connect MDx platform for automated samples processing in molecular diagnostic laboratories which will be available in North America, Europe and other markets now.

HPV Testing and PAP Testing Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

17.1%

Largest Market

North America

Fastest Growing Market

Asia Pacific

HPV Testing and PAP Testing Market Dynamics

The increased prevalence of cervical cancer is driving the demand for PAP and HPV testing around the globe. The growing number of cervical cancers in women aged of 25–55 years is due to a lack of awareness and knowledge. According to WHO, cervical cancer is the leading cause of death in females around the world. The market for HPV testing is growing due to the high demand for the replacement of cytology screening with HPV testing for cervical cancer elimination due to its accuracy. Also, the government takes the initiative by running some funding programs that offer cervical cancer programs to women aged 21 and older to educate them about the severity of the disease (cervical cancer) among them and provide the treatment at early stage. Another method adopted by the government is offering women the option to self-collect vaginal and cervical samples at home, which has significantly increased their participation in screening programs and has reduced the financial, potential and logistical burden for the patients. This self-testing technique also contributed to the another driving factor like technology advancement. Recently few advancements in technology like Microfluid and Lab-on-a-chip technology, Nanomaterial enhancing assay sensitivity, Isothermal amplification technique as rapid alternatives to PCR etc have contributed towards the development of HPV and PAP test in the market.

HPV Testing and PAP Testing Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024-2030

Market Size in 2023

US$ 2,567.2 million

Market CAGR

17.1%

By Type

  • Primary HPV testing
  • Co-testing
  • PAP testing

By Application

  • Cervical cancer
  • Vaginal cancer

By End User

  • Hospital
  • Diagnostic centres
  • Research Institute
  • Others

Key Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Download Free Sample Report

Frequently Asked Questions

The market growth is driven by the government initiative and funding programs and technological advancement in PAP and HPV tests, increasing awareness among the people about the screening program of cervical cancer worldwide, the growing aging population and the increasing prevalence of cervical cancer cases.

As per American Cancer Society, HPV test detects HPV infection and do not detect pre cancer or cancer itself whereas PAP test finds changes in the cells or abnormal cells in the cervix and cannot detect HPV.

Recently few advancements in technology like Microfluid and Lab-on-a-chip technology, Nanomaterial enhancing assay sensitivity, Isothermal amplification technique as rapid alternatives to PCR etc have contributed towards the development of HPV and PAP test in the market.

Asai-Pacific is the fastest-growing region in the HPV and PAP testing market.

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1.Executive Summary
2.Global HPV Testing and PAP Testing Market Introduction 
2.1.Global HPV Testing and PAP Testing Market  - Taxonomy
2.2.Global HPV Testing and PAP Testing Market  - Definitions
2.2.1.Type 
2.2.2.Application
2.2.3.End User
2.2.4.Region
3.Global HPV Testing and PAP Testing Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global HPV Testing and PAP Testing Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global HPV Testing and PAP Testing Market  By Type , 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. Primary HPV testing
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Co-testing
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. PAP testing
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
6.Global HPV Testing and PAP Testing Market  By Application, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. Cervical cancer
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Vaginal cancer
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
7.Global HPV Testing and PAP Testing Market  By End User, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. Hospital
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Diagnostic centres
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Research Institute
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Others
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
8.Global HPV Testing and PAP Testing Market  By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Middle East and Africa (MEA)
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Latin America
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9.North America HPV Testing and PAP Testing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. Type  Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Primary HPV testing
9.1.2.Co-testing
9.1.3.PAP testing
9.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Cervical cancer
9.2.2.Vaginal cancer
9.3.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Hospital
9.3.2.Diagnostic centres
9.3.3.Research Institute
9.3.4.Others
9.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10.Europe HPV Testing and PAP Testing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1. Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Primary HPV testing
10.1.2.Co-testing
10.1.3.PAP testing
10.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Cervical cancer
10.2.2.Vaginal cancer
10.3.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Hospital
10.3.2.Diagnostic centres
10.3.3.Research Institute
10.3.4.Others
10.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Germany
10.4.2.France
10.4.3.Italy
10.4.4.United Kingdom (UK)
10.4.5.Spain
11.Asia Pacific (APAC) HPV Testing and PAP Testing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1. Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Primary HPV testing
11.1.2.Co-testing
11.1.3.PAP testing
11.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Cervical cancer
11.2.2.Vaginal cancer
11.3.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Hospital
11.3.2.Diagnostic centres
11.3.3.Research Institute
11.3.4.Others
11.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.China
11.4.2.India
11.4.3.Australia and New Zealand (ANZ)
11.4.4.Japan
11.4.5.Rest of APAC
12.Middle East and Africa (MEA) HPV Testing and PAP Testing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1. Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Primary HPV testing
12.1.2.Co-testing
12.1.3.PAP testing
12.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Cervical cancer
12.2.2.Vaginal cancer
12.3.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Hospital
12.3.2.Diagnostic centres
12.3.3.Research Institute
12.3.4.Others
12.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.GCC Countries
12.4.2.South Africa
12.4.3.Rest of MEA
13.Latin America HPV Testing and PAP Testing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
13.1. Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Primary HPV testing
13.1.2.Co-testing
13.1.3.PAP testing
13.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Cervical cancer
13.2.2.Vaginal cancer
13.3.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Hospital
13.3.2.Diagnostic centres
13.3.3.Research Institute
13.3.4.Others
13.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Brazil
13.4.2.Mexico
13.4.3.Rest of LA
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1.Abbott Laboratories.
14.2.2.Qiagen N.V.
14.2.3.Roche Diagnostics.
14.2.4.Hologic Inc.
14.2.5.Dickinson and company.
14.2.6.Quest Diagnostic
14.2.7.ONCO health corporation
14.2.8.Seegene Inc.
14.2.9.Femasys Inc.
14.2.10.Thermo Fisher Scientific Inc.
15. Research Methodology 
16. Appendix and Abbreviations 

Key Market Players

  • Abbott Laboratories.
  • Qiagen N.V.
  • Roche Diagnostics.
  • Hologic Inc.
  • Dickinson and company.
  • Quest Diagnostic
  • ONCO health corporation
  • Seegene Inc.
  • Femasys Inc.
  • Thermo Fisher Scientific Inc.

Related Industry Reports